BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 26, 2026
Breaking News: Single-cell transcriptome study points to new drug targets for preeclampsiaBreaking News: Single-cell transcriptome study points to new drug targets for preeclampsiaBreaking News: Science fiction realized: BCI tech is here
Home » Topics » BioWorld Science

BioWorld Science
BioWorld Science RSS Feed RSS

Cross-section of brain
Neurology/Psychiatric

Ifi27l2a identified as new therapeutic target to reduce brain injury in stroke

Feb. 23, 2023
Microglial cells (MGs) are resident immune cells in the brain, which play a key role in the acute response and chronic recovery to stroke. Investigators at the University of Texas Health Science Center Houston aimed to evaluate MG transcriptomic response to stroke in mouse brain.
Read More
3D representation of tumor
Cancer

CTDNEP1 acts as a tumor suppressor in highly aggressive MYC-driven medulloblastomas

Feb. 23, 2023
Medulloblastomas (MBs) are the most common malignant brain tumors in pediatric patients. Among the different types of MBs, those driven by MYC amplification present the worst prognosis. In a recent study published in Nature Communications, scientists from Cincinnati Children's Hospital Medical Center and collaborators investigated the molecular and genetic events triggering MYC amplification and malignant transformation in MBs, which remained previously unclear.
Read More
Cancer

Rebecsinib reverses ADAR1-driven malignant reprogramming in preclinical studies

Feb. 23, 2023
Adenosine deaminase acting on RNA1 (ADAR1) p150 is an inflammation-induced protein isoform of ADAR1 involved in immune silencing, metastasis...
Read More
Immuno-oncology

Fapon receives IND clearance from FDA for anti-CD47 IgG4 monoclonal antibody FP-002

Feb. 23, 2023
Fapon Biopharma, a subsidiary of Guangdong Fapon Biotech Co. Ltd., has received IND clearance by the FDA for clinical trials of FP-002...
Read More
3D illustration of heart cross section
Cardiovascular

Preclinical profile of novel cardiac myosin inhibitor CK-586 disclosed

Feb. 23, 2023
Hypertrophic cardiomyopathy (HCM) is an inherited disorder where different mutations in cardiac myosin lead to hypercontractility of...
Read More
Endocrine/Metabolic

Post exercise, fibronectin drives insulin sensitization via liver autophagy

Feb. 23, 2023
By Subhasree Nag
Researchers led by Congcong He at Northwestern University have found that exercise caused contracting muscles to secrete a glycoprotein called fibronectin (FN1) that induced autophagy in the liver which, in turn, drove insulin sensitization. They reported their findings online in Cell Metabolism on Feb. 21, 2023. He is an assistant professor of cell and developmental biology at the Feinberg School of Medicine.
Read More
HIV-infected cell
HIV/AIDS

Path to a broadly effective HIV vaccine is coming into focus

Feb. 23, 2023
By Anette Breindl
In the larger picture, the fight against HIV has been a triumph of modern medicine. A patient diagnosed with HIV in the 1980s had a remaining life expectancy of 1 to 2 years. In 2023, they can expect to live another half century. But so far, an HIV vaccine has remained elusive. In the newest phase III failure, Janssen Pharmaceutical Cos. of Johnson & Johnson closed down its Mosaico trial more than a year ahead of schedule, following a data and safety monitoring board’s (DSMB) report saying the study was not expected to hit its primary endpoint.
Read More

Other news to note for Feb. 23, 2023

Feb. 23, 2023
Additional early-stage research and drug discovery news in brief, from: Enzolytics, Hibercell.
Read More
Cancer

Toyama University discovers new compounds for pancreatic cancer

Feb. 22, 2023
Toyama University has described compounds reported to be useful for the treatment of pancreatic cancer.
Read More
Neurology/Psychiatric

Nura Bio presents new SARM1 inhibitors for neurological disorders

Feb. 22, 2023
Nura Bio Inc. has divulged NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors reported to be useful for the treatment of neurological disorders.
Read More
Previous 1 2 … 1238 1239 1240 1241 1242 1243 1244 1245 1246 … 18135 18136 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 24, 2026.
  • Cell nucleus architecture

    4D Nucleome opens new wave of gene regulation research, discovery

    BioWorld
    After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
  • Drug capsule spilling onto brain

    Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s

    BioWorld Science
    Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
  • Business pipeline illustration

    Transcripta Bio raises funding to advance neuro pipeline

    BioWorld Science
    Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
  • Other news to note for July 22, 2026

    BioWorld
    Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing